Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Centene Corp    CNC

Delayed Quote. Delayed  - 10/25 10:00:47 pm
65.36 USD   +3.66%
10/25 CENTENE : misses Street 3Q forecasts
10/25 CENTENE CORPORA : Reports 2016 Third Quarter Results
10/24 CENTENE : MHS Health presents Lillian Oduwole, APNP FNP-BC, with 9th..
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Centene : misses Street 3Q forecasts

share with twitter share with LinkedIn share with facebook
share via e-mail
10/25/2016 | 12:14pm CEST

ST LOUIS (AP) _ Centene Corp. (CNC) on Tuesday reported third-quarter net income of $145 million.

The St. Louis-based company said it had profit of 83 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, were $1.11 per share.

The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.15 per share.

The healthcare company posted revenue of $10.85 billion in the period, which also fell short of Street forecasts. Seven analysts surveyed by Zacks expected $10.93 billion.

Centene expects full-year earnings in the range of $4.28 to $4.38 per share, with revenue in the range of $39.4 billion to $40 billion.

Centene shares have dropped 4 percent since the beginning of the year. The stock has increased 14 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNC at http://www.zacks.com/ap/CNC

Keywords: Centene, Earnings Report

Automated Insights, source Associated Press News

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CENTENE CORP
10/25 CENTENE : misses Street 3Q forecasts
10/25 CENTENE : Management's Discussion and Analysis of Financial Condition and Result..
10/25 CENTENE CORP : Results of Operations and Financial Condition, Financial Statemen..
10/25 CENTENE CORPORATION : Reports 2016 Third Quarter Results
10/24 CENTENE : MHS Health presents Lillian Oduwole, APNP FNP-BC, with 9th Annual Summ..
10/20 CENTENE CORP : Khang & Khang LLP Announces an Investigation of Centene Corp. and..
10/20 Investigation of Centene Corp. Announced by Law Offices of Howard G. Smith
10/20CENTENE CORP : quaterly earnings release
10/20 CENTENE : subsidiary awarded expanded Medicaid contract in Missouri
10/18 CENTENE : subsidiary awarded expanded Medicaid contract in Missouri
More news
Sector news : Managed Healthcare - NEC
10/25DJHUMANA : ACA Deadline Extended for Those Who Lost Their Health Plans
10/21DJCIGNA : Ends Preauthorization for Medication to Treat Opioid Addiction
10/18DJUNITEDHEALTH : Tops Views, Boosts Outlook
10/18DJZenefits Touts New Software in Turnaround Effort
10/18 UnitedHealth sees more growth in 2017 when it exits Obamacare
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
10/25 Centene (CNC) Q3 2016 Results - Earnings Call Transcript
10/25 Centene Q3 top line up 86%; net income up 56%; year-to-date cash flow ops dow..
10/25 WALL STREET BREAKFAST : Apple Earnings Take Center Stage
10/25 Centene EPS in-line, misses on revenue
10/25 Obamacare rates up 25% in 2017
Financials ($)
Sales 2016 39 893 M
EBIT 2016 1 392 M
Net income 2016 529 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 24,53
P/E ratio 2017 14,87
Capi. / Sales 2016 0,27x
Capi. / Sales 2017 0,24x
Capitalization 10 765 M
More Financials
Duration : Period :
Centene Corp Technical Analysis Chart | CNC | US15135B1017 | 4-Traders
Full-screen chart
Technical analysis trends CENTENE CORP
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 80,4 $
Spread / Average Target 27%
Consensus details
EPS Revisions
More Estimates Revisions
Michael F. Neidorff Chairman, President & Chief Executive Officer
Jeffrey A. Schwaneke Chief Financial Officer & Executive Vice President
Ken Yamaguchi Chief Medical Officer & Executive Vice President
Mark J. Brooks Chief Information Officer & Senior Vice President
David L. Steward Independent Class II Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CENTENE CORP-4.19%10 765
AETNA INC3.61%39 297
ANTHEM INC-10.72%32 762
HUMANA INC-1.25%26 276
More Results